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Abstract Article Info 
Introduction: Nasopharyngeal carcinoma is the most common malignancy in the ENT field. The cause of 
nasopharyngeal carcinoma is multifactorial. One of the risk factors for an increase in nasopharyngeal carcinoma 
is the rs2070672 polymorphism of the CYP2E1 gene..  
Objective: To determine the rs2070672 CYP2E1 gene polymorphism proportion in early and advanced stage 
undifferentiated type NPC subjects in Balinese.   
Method: This research is a cross-sectional comparative study. The case population was all subjects with 
undifferentiated type NPC in the ENT outpatient clinic at Sanglah General Hospital Denpasar. This study uses 
65 samples. Data collected in the form of subject characteristics and rs2070672 CYP2E1 gene polymorphisms 
which examined by the ARMS-PCR technique. 
Result: The average age of the sample was 48.1 years, the most were male as many as 48 subjects (73.8%), and 
the highest was the advanced stage as many as 56 subjects (86.2%). In the chi-square test, the proportion of 
polymorphisms in the advanced stage was 2.357 times higher than the early stages. The results of the 
multivariate analysis using logistic regression proved that the rs2070672 CYP2E1 gene polymorphism at the 
advanced stage was 7.469 times higher than the early stage. 
Conclusion: There is a difference in the proportion of rs2070672 CYP2E1 gene polymorphism in 
undifferentiated type NPC of Balinese, where the advanced stage is higher than the early stage.  
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1. INTRODUCTION 
Nasopharyngeal carcinoma (NPC) is a malignancy of the surface 
epithelium in the nasopharynx. The incidence rate in men has doubled 
compared to women. The incidence of NPC is 1.2 per 100,000 
populations per year, with diverse geographical spreads throughout the 
world [1]. The prevalence of NPC in Indonesia is highest in the 4-5 
decade with a ratio between men and women is 2-3:1 and reaches 4.7 
per 100,000 populations per year [2]. 
Nasopharyngeal carcinoma risk factors consist of internal and 
external factors. Internal factors are genetic mechanisms. External 
factors are Epstein-Barr virus (EBV) infection, exposure to cigarette 
smoke, wood dust, formaldehyde, and consuming preserved food [3]. 
One of the genes polymorphisms at risk for NPC is the cytochrome 
P450 family 2 subfamily E polypeptide 1 (CYP2E1) gene that codes for 
the CYP2E1 enzyme for activation of procarcinogens [4]. The highest 
prevalence of NPC in Indonesia is in Yogyakarta (4.1 ‰), followed by 
Central Java (2.1 ‰), Bali (2 ‰), Bengkulu, and Jakarta with 1.9 ‰ 
respectively [5]. Study of the relationship of CYP2E1 gene 
polymorphism with the risk of NPC in Yogyakarta with buffy coat 
isolation DNA of 119 male NPC patients and 119 controls of Javanese 
men showed mutant alleles at rs3813865 and rs2070672 increased the 
risk of NPC and the progression of the disease, whereas the mutant 
allele of rs3813867 reduced the risk of NPC [6]. 
The rs2070672 polymorphism of the CYP2E1 gene is one of the 
NPC biomarkers that need to be investigated because there is a strong 
association between the polymorphism of the rs2070672 CYP2E1 gene 
with the incidence of NPC. Research on the rs2070672 polymorphism 
of the CYP2E1 gene in subjects with NPC in Indonesia is still rare, 
while it has never been studied in Bali. 
2. MATERIAL AND METHODS 
A total of 65 undifferentiated type NPC in Balinese subjects who 
underwent nasopharyngeal biopsy at Sanglah Hospital and 
histopathological examination at the Anatomy Pathology Laboratory of the 
Faculty of Medicine, Udayana University/Sanglah Hospital Denpasar from 
January 2017 to December 2018 were included in the inclusion criteria. 
Samples were taken by consecutive sampling. The study was conducted in 
August - September 2019. This is an observational study with cross-
sectional comparative study design. Data were analyzed by univariate, 
bivariate, and multivariate analysis. Characteristics of the study subjects 
included age, gender, clinical stage of undifferentiated type NPC, and 
rs2070672 polymorphism of the CYP2E1 gene. The statistical test used was 
the Chi-Square Test by looking at 95% confidence interval (CI) and the p-
value at the significance of 0.05. Multivariate analysis was done using 
logistic regression. Data processing is performed using the SPSS computer 
program ver. 22.0 for Windows. 
3. RESULT 
This study using 65 samples conducted in August-September 2019. 
Table 1. Characteristic of subject 
Characteristic  n=65 
Age (year) 
   Average±SD 
   Min-Max 
 
48.1±11.1 
17-73 
Gender 
   Male  
   Female 
 
48 (73.8%) 
17 (26.2%) 
 
 
 
International Journal of Nasopharyngeal Carcinoma (IJNPC) Vol. 01, No. 01, 2020 | 10-12 
 
 
 
  
11 
 
Table 1 shows that the average age of the subjects was 48.1 years with 
a standard deviation of 11.1 years. The youngest is 17 years old and the 
oldest is 73 years old. The gender proportion is male as many as 48 subjects 
(73.8%) and female as many as 17 subjects (26.2%). 
Table 2. Clinical stage of an undifferentiated type of NPC 
Variable 
(n=65) 
n (%) 
T (Tumor)  
   1 
   2 
   3  
   4 
 
1 (1.5%) 
14 (21.6%) 
16 (24.6%) 
34 (52.3%) 
N (Nodule) 
   0 
   1 
   2 
   3 
 
9 (13.8%) 
18 (27.7%) 
16 (24.6%) 
22 (33.9%) 
M (Metastasis) 
   0 
   1 
 
63 (96.9%) 
2 (3.1%) 
Clinical stage 
   Stage I 
   Stage II 
   Stage III 
   Stage IV A 
   Stage IV B 
 
0 (0%) 
9 (13.8%) 
12 (18.5%) 
19 (29.2%) 
25 (38.5%) 
Early-stage 9 (13.8%) 
Advanced stage 56 (86.2%) 
 
Distribution based on the clinical stage of an undifferentiated type of 
NPC in this study was stage II in 9 subjects (13.8%), stage III in 12 subjects 
(18.5%), stage IVA in 19 subjects (29.2%), and stage IVB as many as 25 
subjects (38.5%). Initial stages were found in 9 subjects (13.8%) and 
advanced stages as many as 56 subjects (86.2%). This result is in correspond 
with Hasibuan et al (2014), whose obtain 62.5% subjects with stage IV NPC 
and none stage I NPC [7]. Study in Europe obtain as many as 39.1% of early 
stage NPC and 60.9% of late stage NPC [8]. Study in Djamil Hospital 
Padang obtain as many as 13.64% of early stage NPC and 86.3% of late 
stage NPC. This shows patients come in the late stage. Nasopharyngeal 
carcinoma often shows minimal or unspecific sign, so it often found in late 
stage with lymph node enlargement and intracranial invasion [9]. 
Table 3. Allele and rs2070672 polymorphism CYP2E1 gene 
Variable 
(n=65) 
n (%) 
Allele rs2070672 CYP2E1gene 
   Allele AA 
   Allele AG 
   Allele GG 
 
18 (27.7%) 
8 (12.3%) 
39 (60.0%) 
Polymorphism 
   Present  
  Not present 
 
47 (72.3%) 
18 (27.7%) 
The proportion of allele rs2070672 CYP2E1 gene in subjects with 
undifferentiated type NPC in this study was 18 AA allele (27.7%), AG allele 
in 8 subjects (12.3%), and GG allele in 39 subjects (60.0%). Comparison of 
the proportion of rs2070672 polymorphism of CYP2E1 gene in subjects 
with undifferentiated type NPC were polymorphisms (allele AG and GG) in 
47 subjects (72.3%) and no polymorphisms/wild types (AA alleles) in 18 
subjects (27.7%). 
Study by Yin (2012) shows SNP rs2070672 G allele (GG) homozygote 
found in 7.9% from 447 subjects compare with 3.1% from 487 control. GG 
genotype is related with increased risk NPC compared with GA and AA 
genotype (OR = 3.57 and 9.5% CI = 1.66 – 7.66 recessive inherited) [10]. 
Table 4. The proportion of rs2070672 polymorphism CYP2E1 gene 
based on the clinical stage of undifferentiated type NPC in Balinese 
Variable 
Polymorphism 
PR 95% CI P 
Present Not present 
Stage 
   Advanced 
   Early 
 
44 (78.6%) 
3 (33.3%) 
 
12 (21.4%) 
6 (66.7%) 
 
2.357  
(0.926-5.998) 
 
0.011 
In the advanced stage, as many as 44 subjects (78.6%) and early stages as 
many as 3 subjects (33.3%) experienced polymorphism rs2070672 CYP2E1 
gene. Patients with advanced-stage NPC as many as 12 subjects (21.4%) and 
early-stage as many as 6 subjects (66.7%) who did not experience 
polymorphism in rs2070672 CYP2E1 gene (wild type). Chi-square test results 
obtained the proportion of polymorphism in the advanced stage is 2.357 times 
compared to the early stage with a confidence interval (CI) 0.926-5.998 and a 
p-value = 0.011 (P<0.05), meaning statistically significant. 
 
 
Table 5. The result of multivariate analysis (logistic regression) 
Variable Adjusted Odds Ratio 95% CI P 
Polymorphism 
Age  
Gender 
7.469 
1.005 
1.553 
1.586-35.177 
0.939-1.076 
0.289-8.357 
0.011 
0.877 
0.608 
The results of the multivariate analysis using logistic regression proved 
that the rs2070672 polymorphism of the CYP2E1 gene at an advanced stage 
was 7.469 times higher than the early stage with a confidence interval (CI) 
1.586-35.177 and P-value = 0.011 (P<0.05) after controlling for age and sex. 
4. DISCUSSION 
A total of 65 subjects were included in this study with ages ranging from 
17 to 73 years with an average age of 48.1±11.1 years. This shows that the 
age distribution in the study subjects is normal and in accordance with the 
existing literature, NPC rarely occurs at the age of fewer than 20 years. This 
is consistent with Razek and King's research, which states that the peak age 
of nasopharyngeal carcinomas is 40-60 years [11]. In Cantonese, the 
incidence increases with age and peaks at the age of 40 - 59 years and then 
decreases [12]. In Turkey, NPC occurs mostly at the age of 40-50 years [13]. 
It is estimated that about 80% of NPC is found at the age of 35-50 years 
with a peak age of 40-49 years [14]. NPC most commonly occurs at the age 
of 40 - 49 years at Cipto Mangunkusumo Hospital in Jakarta and more than 
80% of patients are diagnosed at the age of 30-59 years [15]. 
Cancer cells arise from normal cells that are transformed into malignant 
due to spontaneous mutations or induction of carcinogens. Long induction 
time is needed from the time of contact with carcinogens to the appearance 
of cancer cells, up to 15-30 years [16]. NPC tends to occur at the age of 
more than 40 years because of a decreased immune system which cannot 
eliminate tumor antigens or EBV viruses properly. DNA repair mechanism 
that is not functioning properly causes failure to repair gene mutations 
resulting in uncontrolled cell growth. The incidence of  NPC is often found 
at the age of more than 40 years related to the length of exposure to 
carcinogenic substances such as nitrosamines found in salted fish and 
cigarette consumption for more than 25 years [3]. 
There were more male than female NPC patients in this study, as many 
as 48 subjects (73.8%), with a ratio of 2.8:1. This is consistent with several 
other studies that found the proportion of men with NPC was greater than 
women with a ratio of 2-3: 1 [12]. Nurdiansyah et al. stated the ratio of men 
and women is 2.7: 1 [13]. Adham et al. stated the comparison according to 
gender are 70.4% in men and 29.6% in women with a ratio of 2.4: 1 [15]. 
Hasibuan et al. reported the incidence rate of NPC in males and females was 
3: 1 [7]. The high incidence in men is thought to be due to occupational 
factors and life habits that are more often exposed to carcinogens [13].  
The distribution of subjects based on the clinical stage of 
undifferentiated type NPC in the Balinese was an early stage as many as 9 
subjects (13.8%) and an advanced stage as many as 56 subjects (86.2%). 
This is in accordance with several studies such as Hasibuan et al. as many 
as 62.5% of patients with stage IV NPC and no patient in stage I [7]. 
Research in Europe found 39.1% of patients with early-stage NPC and 
60.9% of patients with advanced-stage [7]. Research in Padang Djamil 
Hospital stated early-stage NPC in 13.64% and advanced stages in 86.36%. 
This shows that most of the patients come for treatment at an advanced 
stage. The diagnosis of NPC is often made late because the location of the 
nasopharynx is hidden behind the nasal cavity and under the base of the 
skull so that NPC patients generally come for treatment at an advanced 
stage. In addition, NPC often exhibits minimal or nonspecific symptoms so 
it often found at an advanced stage with enlarged lymph nodes and 
intracranial invasion [9]. 
The description of the rs2070672 allele CYP2E1 gene in 
undifferentiated type NPC patients in Balinese was AA allele in 18 subjects 
(27.7%), AG allele in 8 subjects (12.3%), and GG allele in 39 subjects 
(60.0%). This shows that the majority of NPC patients in this study 
experienced polymorphisms (alleles AG and GG) as many as 47 subjects 
(72.3%). 
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Picture 1. The result of ARMS-PCR primary tetra to detect allele 
rs2070672 in this study 
This is consistent with the results of several previous studies. Yin stated 
homozygous SNP rs2070672 allele G (GG) was present in 7.9% of 447 NPC 
patients compared with 3.1% of 487 controls. Genotype GG is associated 
with an increased risk of NPC compared to GA and AA genotypes (OR=3.57 
and 95% CI=1.66-7.66 which inherited recessively) [10]. 
Tang et al. comparing NPC patients in several cities e.g Shantou, 
Shanghai, Shenyang, Xian, and China with a total of 400 NPC patients. In each 
city, several specific rs genes were compared as risk factors for nasopharyngeal 
carcinoma. The study sample was 100 NPC patients in each of these cities, 
which consisted of 50 male patients and 50 female patients, aged 18-53 years. 
The proportion of polymorphism rs2070672 alleles G rs2070672 in each city 
is as follows: Shantou (18.8%), Shanghai (14.1%), Shenyang (18.8%), Xian 
(21.9%), and China (18.4%). This study also compared polymorphisms on 
rs2070672 with other ethnicities. In this study (China), the polymorphism of 
rs2070672 was 33.9% from 400 samples where the proportion was higher than 
that of Northern Europe (5.2% of 115 subjects), Germany (3.7% of 299 
subjects), and Turkey (6, 8% of 206 subjects) [18]. 
A case-control study by Wang et al in the Chinese Tibet population 
where 50 patients NPC as case and 50 patients as control, showing G allele 
polymorphism in 30 subjects in case group and 5 subjects in control group. 
This result is higher than the proportion of G allele rs2070672 in Africa-
America, Europe-America, and Korea. This result is statistically significant 
with P-value=0,01 (P<0.05) and allele GG polymorphism increased the risk 
of NPC to 2.9 times [19]. 
In this study, polymorphism was found in the rs2070672 CYP2E1 gene 
at an advanced stage as many as 44 subjects (78.6%) and in the early stages 
as many as 3 subjects (33.3%). Subjects with advanced stage NPC were 12 
subjects (21.4%) and early-stage were 6 subjects (66.7%) who did not 
experience polymorphism in the rs2070672 CYP2E1 gene (wild type). Chi-
square test shows the proportion of polymorphism in the advanced stage 
2.357 times compared to the initial stage with a confidence interval (CI) 
0.926-5.998 and P=0.011 (P <0.05) so statistically significant. 
The results of the multivariate analysis using logistic regression proved 
that the rs2070672 polymorphism of the CYP2E1 gene at an advanced stage 
was 7.469 times higher than the initial stage with a confidence interval (CI) 
1.586-35.177 and a value of P=0.011 (P<0.05) after controlling for age and 
sex. Yin's study of the rs2070672 polymorphism in NPC patients in 
Malaysia reported statistically significant results with a P-value of 0.04 
(P<0.05) and the probability of the occurrence of GG and AG allele 
polymorphisms in the rs2070672 CYP2E1 gene in undifferentiated type 
NPC was 1.25 times greater in patients with advanced stages [10]. 
A case-control study by Wang et al. in the Tibetan Chinese population, 
there is a chance that the rs2070672 polymorphism of the CYP2E1 gene in 
undifferentiated type NPC is 2.6 times greater in patients with advanced-
stage with 95% CI values of 1.2-5.7 [19]. Examination of the rs2070672 
allele polymorphism of the CYP2E1 gene can be used as a supporting 
modality to assess tumor growth, progression, and disease prognosis. This 
is in accordance with several previous studies whose found alleles 
polymorphism of the rs2070672 CYP2E1 gene was significantly associated 
with cancer metastasis to the lymph nodes and the clinical stage [18]. 
An increase in the proportion of rs2070672 polymorphism of the 
CYP2E1 gene is associated with worse overall survival (OS) and disease-
free survival (DFS) on observation for 5 years. The alleles polymorphism of 
the rs2070672 CYP2E1 gene can be used as a prognostic factor for NPC 
[20]. Gene polymorphisms related to carcinogenic metabolism are one of 
the risk factors for NPC. One of them is the cytochrome P450 gene family 
2 subfamily E polypeptide 1 (CYP2E1) which codes the CYP2E1 enzyme 
for activation of procarcinogens [19]. 
5. CONCLUSION 
There is a difference in the proportion of rs2070672 polymorphism of 
the CYP2E1 gene in patients with an undifferentiated type of NPC in 
Balinese, which advanced stage is 2.357 times higher than the early stage..  
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